Singapore markets closed

PsyBio Therapeutics Corp. (PSYB.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.00050.0000 (0.00%)
At close: 09:04AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 63.77k
Enterprise value 141.16k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)145.88
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.05

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-97.14%
S&P500 52-week change 322.38%
52-week high 30.0290
52-week low 30.0005
50-day moving average 30.0005
200-day moving average 30.0022

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 580.85M
Implied shares outstanding 61.74B
Float 879.1M
% held by insiders 16.27%
% held by institutions 13.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-209.00%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -2.52M
Net income avi to common (ttm)-1.9M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.37k
Total cash per share (mrq)0
Total debt (mrq)96.14k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.05
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-1.59M
Levered free cash flow (ttm)-343.08k